Facebook Twitter Instagram Linkedin Youtube
Facebook Twitter

Pandemic Latest News

Click Here

Featured

CDC votes to add COVID-19 vaccines to child immunisation schedules

Leave a Comment / covid, Featured, infectious diseases, News, Newsletter, sars-cov-2 /

Independent advisers of the US Centers for Disease Control and Prevention (CDC) voted 15-0 last Thursday to add most COVID-19 vaccines offered in the US to the childhood, adolescent and adult immunization schedules. www.politico.com/news/2022/10/20/cdc-advisers-recommend-adding-covid-shots-to-routine-schedules-for-kids-adults-00062739? The immunization schedules, which are updated every autumn before going into effect the following year, consolidate all of the CDC’s vaccine […]

CDC votes to add COVID-19 vaccines to child immunisation schedules Read More »

China doubles down on “zero-COVID” strategy

Leave a Comment / covid, Featured, infectious diseases, News, Newsletter, sars-cov-2 /

Chinese President Xi Jinping touted his country’s “zero-COVID” strategy at the just concluded Communist Party’s National Congress, dashing any hopes that China’s rigid regime of quarantines, mass testing, and lockdowns may soon come to an end. www.science.org/content/article/news-glance-climate-justice-ethical-mask-wearers-and-cdc-under-trump The strategy has crimped the economy, and public health experts say the obstacles to lifting it are now

China doubles down on “zero-COVID” strategy Read More »

Study finds long-COVID eases with time

Leave a Comment / covid, Featured, infectious diseases, News, Newsletter, sars-cov-2 /

Long COVID eases with time, according to a study that found about 1% of coronavirus patients had persistent symptoms for a year or more. In the first rigorous assessment of the magnitude of long COVID on a global scale, researchers found 6.2% of people who had COVID-19 in the pandemic’s first two years experienced at

Study finds long-COVID eases with time Read More »

Pfizer quadruples price of COVID-19 vaccines

Leave a Comment / covid, Featured, infectious diseases, News, Newsletter, sars-cov-2 /

Pfizer’s plan to quadruple US prices for its COVID-19 vaccine next year is beyond Wall Street’s expectations and will spur its revenue for years despite weaker than anticipated demand for the new booster shot so far, analysts said. www.reuters.com/business/healthcare-pharmaceuticals/pfizer-covid-vaccine-price-hike-seen-giving-revenue-boost-years-2022-10-21/? The drugmaker, which developed and sells the vaccine with Germany’s BioNTech (22UAy.DE), said on Thursday evening

Pfizer quadruples price of COVID-19 vaccines Read More »

BQ.1 Omicron strains increasing in prevalence

Leave a Comment / covid, Featured, infectious diseases, News, Newsletter, sars-cov-2 /

United States (US) health regulators on Friday estimated that BQ.1 and closely related BQ.1.1 accounted for 16.6% of coronavirus variants in the country, nearly doubling from last week, while Europe expects them to become the dominant variants in a month. The European Centre for Disease Prevention and Control said the variants are likely to drive

BQ.1 Omicron strains increasing in prevalence Read More »

COVID-19 deaths rise in England and Wales

Leave a Comment / covid, Featured, infectious diseases, News, Newsletter, sars-cov-2 /

The number of COVID-related deaths in England and Wales increased by nearly 40% in a week and reached their highest number since August. The latest data from the Office for National Statistics (ONS) shows some 400 deaths registered in the seven days to 7 October mentioned coronavirus on the death certificate. The figure climbed 39%

COVID-19 deaths rise in England and Wales Read More »

Clinical trial for monkeypox medication starts in the Democratic Republic of the Congo

Leave a Comment / Democratic Republic of Congo, Featured, infectious diseases, News, Newsletter /

A clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the Congo (DRC). The trial will evaluate the drug’s safety and its ability to mitigate monkeypox symptoms and prevent serious outcomes, including death. www.nih.gov/news-events/news-releases/monkeypox-treatment-trial-begins-democratic-republic-congo? The National Institute of Allergy

Clinical trial for monkeypox medication starts in the Democratic Republic of the Congo Read More »

Pourquoi certains efforts en matière de santé mondiale échouent-ils?

Leave a Comment / covid, Featured, infectious diseases, sars-cov-2 /

Article original publié par Newsweek : Disponible sur https://www.newsweek.com/why-are-some-global-health-efforts-failing-opinion-1751649 HARALD NUSSER RESPONSABLE DES SOLUTIONS GLOBALES POUR LES PATIENTS CHEZ GILEAD SCIENCES Le bilan mondial des décès officiellement attribués au COVID-19 s’élève à plus de 6,5 millions. Et lorsque les chercheurs incluent les décès qui sont probablement dus à la pandémie, le bilan est beaucoup plus

Pourquoi certains efforts en matière de santé mondiale échouent-ils? Read More »

Por que algumas iniciativas globais na área da saúde não estão sendo eficazes?

Leave a Comment / covid, Featured, infectious diseases, sars-cov-2 /

Artigo original publicado pela Newsweek: Disponível em https://www.newsweek.com/why-are-some-global-health-efforts-failing-opinion-1751649 HARALD NUSSER DIRETOR DA DIVISÃO “GLOBAL PATIENT SOLUTIONS” DA EMPRESA GILEAD SCIENCES O número oficial de mortos em decorrência da COVID-19 já ultrapassa 6,5 milhões de pessoas. E, quando nesta estatística os pesquisadores incluem os casos de mortes que de algum modo também estão associadas à pandemia,

Por que algumas iniciativas globais na área da saúde não estão sendo eficazes? Read More »

Why Are Some Global Health Efforts Failing?

Leave a Comment / covid, Featured, infectious diseases, sars-cov-2 /

Original article published by Newsweek: Available at https://www.newsweek.com/why-are-some-global-health-efforts-failing-opinion-1751649 HARALD NUSSERHEAD OF GLOBAL PATIENT SOLUTIONS AT GILEAD SCIENCES The worldwide death toll officially attributed to COVID-19 stands at more than 6.5 million. And when researchers include deaths that are likely due to the pandemic as well, the toll stands much higher. Many of these tragic deaths

Why Are Some Global Health Efforts Failing? Read More »

About Us

Health Issues Africa is a web portal that tracks key health stories and issues in Africa. On our website, you will find a guide to some of the latest trends, research, reports and journals on health. We provide original interviews and opinions of specialists as well as our own commentary on issues and events.
Facebook Twitter

Newsletter

Subscribe our newsletter to stay updated

Copyright © 2023 | Health Issues Africa | All rights reserved.